In solid tumours, GE11 peptide modified exosomes successfully delivered let-7a miRNA to epidermal growth factor receptor positive breast cancer cells, restoring tumour-suppressor miRNA levels and reducing proliferation in vitro and in vivo (71). The gene discussed is EGFR; the disease is neoplasm.